NEUCHATEL, Suíça–(BUSINESS WIRE)–A SAV-IOL (Swiss Advanced Vision) está avançando no desenvolvimento do Projeto R-TASC, a primeira lente intraocular eletrônica (LIO) com autofoco em tempo real, destinada a restaurar totalmente a visão após a cirurgia…
Author: Business Wire
Riassunto: Dopo il successo della fattibilità tecnica, la società svizzera SAV-IOL sta ora cercando investitori per il progetto lente intraoculare smart attiva per interventi di cataratta
NEUCHATEL, Svizzera–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) sta andando avanti con lo sviluppo del Progetto R-TASC, la prima lente intraoculare (IOL) elettronica autofocalizzante in tempo reale, finalizzata a ristabilire completamente la vista in fase di post-intervento di cataratta. R-TASC intende rivoluzionare il settore dell’oftalmologia nei prossimi 5-7 anni. SAV-IOL ha già confermato la fattibilità tecnica di questo progetto e ora sta cercando di raccogliere 20 milioni di dollari
Luego del éxito de la viabilidad técnica, la empresa suiza SAV-IOL está ahora buscando inversores para un proyecto de lentes intraoculares activos inteligentes para cirugía de cataratas
NEUCHATEL, Suiza–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) está avanzando con el desarrollo del proyecto R-TASC, los primeros lentes intraoculares electrónicos (IOL) con enfoque automático en tiempo real, que tiene por objetivo restaurar comple…
Samenvatting: Na gebleken succesvolle technische haalbaarheid is het Zwitserse bedrijf SAV-IOL op zoek naar investeerders voor het Smart Active Intraocular Lens Project voor cataractchirurgie
NEUCHATEL, Zwitserland–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) gaat verder met de ontwikkeling van het R-TASC-project, de eerste elektronische intraoculaire lens (IOL) met real-time autofocus, die tot doel heeft het zicht na een cataractopera…
Après des essais de faisabilité technique fructueux, la société suisse SAV-IOL est actuellement à la recherche d'investisseurs pour un projet de lentille intra-oculaire intelligente active pour l’opération de la cataracte
NEUCHATEL, Suisse–(BUSINESS WIRE)–SAV-IOL (Swiss Advanced Vision) progresse dans le développement du projet R-TASC, la première lentille intraoculaire électronique (LIO) avec autofocus en temps réel, destiné à restaurer complètement la vision après l…
Aerie Pharmaceuticals Upsizes and Prices Private Offering of $275 Million 1.50% Convertible Senior Notes Due 2024
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, announced today that it has…
Riassunto: Immervision presenta la nuova lente panomorfica Super Wide-Angle 125° FoV con la più alta risoluzione per smartphone
MONTREAL–(BUSINESS WIRE)–Immervision, lo sviluppatore e licenziatario di tecnologia ottica e di imaging grandangolare brevettata annuncia il primo campo visivo (FoV) da 125° super grandangolare del settore con la lente panomorfica a più alta risoluzione e nitidezza d’immagine da un bordo all’altro per smartphone e produttori di fotocamere per consumatori. Il nuovo licenziatario della lente super grandangolare brevettata di Immervision, l’azienda taiwanese Zhong Yang Technology Co., Ltd. (JMO)
Immervision lance un nouvel objectif panomorphe 125° à angle très large avec la plus haute résolution pour Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, la société montréalaise qui développe et concède sous licence des technologies brevetées d’optique grand angle et d’imagerie, annonce la première technologie à très grand angle de l’industrie, doté d’un champ de vision (FoV) de 125° avec la plus haute résolution et la plus grande clarté d’image grâce à l’objectif panomorphe bord à bord pour les fabricants de smartphones et de caméras grand public. Le nouveau titulaire de la licence de l’objectif grand ang
Immervision stellt neues panomorphes Superweitwinkel-Objektiv mit einem Bildwinkel von 125° und höchster Auflösung für Smartphones vor
MONTREAL–(BUSINESS WIRE)–Immervision, der Entwickler und Lizenzgeber patentierter Weitwinkel-Optik- und Bildgebungstechnologie mit Sitz in Montréal, kündigt das branchenweit erste panomorphe Superweitweitwinkel-Objektiv mit einem Bildwinkel von 125° …
My Eyelab, a Leading Eye Health Provider, Plans Retail Expansion in Houston Area with 10 New Locations by 2020
HOUSTON–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/EyeExam?src=hash" target="_blank">#EyeExam</a>–My Eyelab, a Leading Eye Health Provider, Plans
Retail Expansion in Houston Area with 10 New Locations by 2020
My Eyelab, Proveedor Líder de Salud Oftalmológica, Planea una Expansión de Tiendas Minoristas en el Área de Houston con 10 Nuevas Sucursales para 2020
HOUSTON–(BUSINESS WIRE)–My Eyelab, una marca minorista de Now Optics, es un proveedor líder de salud oftalmológica que ofrece servicios para el cuidado de la vista y lentes accesibles y económicos, anunció hoy la expansión de su presencia minorista e…
IVERIC bio to Host Inaugural Gene Therapy R&D Investor Day on September 13, 2019
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that it will host its inaugural Gene Therapy R&D Investor Day in New York on Sept. 13, 2019, from 8:30 a.m. to 11:30 a.m. ET.
Immervision Introduces New Super Wide-Angle 125° FoV Panomorph Lens with Highest Resolution for Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, the Montréal-based developer and licensor of patented, wide-angle optic and imaging technology announces the industry’s first super wide-angle 125° field-of-view (FoV) with highest resolution and image clarity ed…
Immervision Introduces New Super Wide-Angle 125° FoV Panomorph Lens with Highest Resolution for Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, the Montréal-based developer and licensor of patented, wide-angle optic and imaging technology announces the industry’s first super wide-angle 125° field-of-view (FoV) with highest resolution and image clarity ed…
Immervision Introduces New Super Wide-Angle 125° FoV Panomorph Lens with Highest Resolution for Smartphones
MONTREAL–(BUSINESS WIRE)–Immervision, the Montréal-based developer and licensor of patented, wide-angle optic and imaging technology announces the industry’s first super wide-angle 125° field-of-view (FoV) with highest resolution and image clarity ed…
STAAR Surgical Announces Strategic Alliance Agreement with Asian Eye Institute
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it has entered a strategic alliance with …
Aerie Pharmaceuticals to Offer $250 Million Convertible Senior Notes Due 2024
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Lineage Cell Therapeutics Announces Data From Vision Restoration Program Published in Stem Cells and Development Journal
CARLSBAD, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24LCTX&src=ctag" target="_blank">$LCTX</a> <a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank">#AMD&l…
Allegro Ophthalmics to Present the Results of Its Phase 2 Risuteganib Intermediate Dry Age-Related Macular Degeneration Study at the 19th EURETINA Congress and The Retina Society 2019 Annual Meeting
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/DME?src=hash" target="_blank">#DME</a>–Allegro Ophthalmics announced that results of its risuteganib US Phase 2 dry AMD study will be pr…